Head-to-Head

Amneal Pharmaceuticals, Inc. Class A Common Stock vs. Eli Lilly & Co.

AMRX

Amneal Pharmaceuticals, Inc. Class A Common Stock

$17.01 +0.83%

VS LLY

Eli Lilly & Co.

$1152.44 +1.28%

Eli Lilly & Co. (LLY) comes out ahead, leading on 6 of 9 compared factors.

Size & Scale

AMRXLLY
Market Cap $5.92 billion $1.03 trillion
Revenue (TTM) $3.12 billion $79.67 billion
Net Income (TTM) $215.32 million $26.71 billion

LLY leads on 3 of 3 size & scale factors.

Valuation

AMRXLLY
P/E Ratio 34.71 38.69
Price / Book 179.40 30.32
Price / Sales 1.90 12.89

AMRX leads on 2 of 3 valuation factors.

Profitability

AMRXLLY
Net Margin 6.91% 33.53%
Return on Equity 652.01% 78.84%

AMRX and LLY split the profitability factors evenly.

Dividend

AMRXLLY
Dividend Yield — 0.60%
Payout Ratio — 23.23

AMRX and LLY split the dividend factors evenly.

Risk & Sentiment

AMRXLLY
Short Interest 2.39% 1.29%

LLY leads on 1 of 1 risk & sentiment factors.

Dig deeper: AMRX overview, AMRX financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.